Archive
Past newsletters of MDDR.
Wednesday, 17 June 2026
New Alzheimer's agitation medication, GLP-1 drugs pilot program, Measles outbreak in Bangladesh
The US Food and Drug Administration (FDA) has approved a new medication specifically for treating agitation associated with dementia due to
Tuesday, 16 June 2026
Victoria ADHD training for GPs, Early egg introduction reduces allergies, Avant opposes pharmacist prescribing
Victoria has opened expressions of interest for GPs to receive training in diagnosing, treating, and prescribing for ADHD in adults and chil
Monday, 15 June 2026
Statin therapy and adverse events, Insights from hantavirus outbreak, Doctors' arts engagement decline
The Cholesterol Treatment Trialists’ Collaboration conducted a meta-analysis of double-blind randomised controlled trials to evaluate the ca
Sunday, 14 June 2026
Pharmacist-led UTI care model, Statin safety reassured, Insulin pricing settlement proposal
The NSW pharmacist-led UTI trial treated over 17,000 women in under a year, demonstrating a structured approach to managing uncomplicated ur
Saturday, 13 June 2026
GPs and firearm licensing calls, New three-tier funding proposal, Urban settlement of overseas GPs
A Victorian coronial inquest has reignited discussions on the role of GPs in assessing firearm licence applicants. The inquest followed the
Thursday, 11 June 2026
FluMist safety update, AMA opposes audiometrist MBS changes, RACGP critiques NDIS reforms
The Therapeutic Goods Administration (TGA) issued a safety update regarding FluMist, the intranasal influenza vaccine, after over 80 childre
Wednesday, 10 June 2026
AI liability concerns for doctors, WHO prequalifies infant malaria treatment, Preoperative nutrition reduces
A report by the Medical Protection Society (MPS) highlights that doctors are increasingly exposed to legal claims due to the evolving use of
Tuesday, 9 June 2026
TGA guidance on compounding medicines, Chronic kidney disease reviews, Myostatin inhibitor for muscle loss
The federal government has issued new guidance clarifying the requirements for compounding medicines, as announced by the TGA. This guidance
Monday, 8 June 2026
GPs recognised in King's Birthday Awards, Pregnancy outcome disparities explored, Gaza humanitarian crisis insights
Fourteen general practitioners received prestigious honours in this year’s King’s Birthday awards, recognising their contributions to primar
Sunday, 7 June 2026
CereVasc's $85M funding secured, Pets in One Health surveillance, Minocycline's modest stroke benefits
CereVasc has raised $85 million in a Series C funding round led by Piper Sandler Merchant Banking, with participation from Johnson & Johnson